MIRA
Mira Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$1.20
+0.07 (+6.19%)
Open$1.17
Previous Close$1.13
Day High$1.23
Day Low$1.15
52W High$21.89
52W Low$15.78
Volume—
Avg Volume328.6K
Market Cap50.25M
P/E Ratio20.87
EPS$0.82
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,819.2% upside
Current
$1.20
$1.20
Target
$23.03
$23.03
$12.17
$23.03 avg
$29.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.23M | 13.68M | 17.07M |
| Net Income | 2.05M | 2.22M | 2.28M |
| Profit Margin | 13.5% | 16.2% | 13.3% |
| EBITDA | 4.17M | 3.79M | 4.72M |
| Free Cash Flow | 3.12M | 1.71M | 2.33M |
| Rev Growth | +3.2% | +10.2% | +2.3% |
| Debt/Equity | 0.43 | 0.37 | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |